Quantus

You have data. You have evidence. And still no decision. It’s not the product. It’s the story. 👉 Swipe 📩 DM VALUE STORY #Pharma #MarketAccess #HEOR #HTA

You won the tender with AI… But the market? ⬇️ -30% prices ⬇️ Margins ⬆️ Risk Winning isn’t always winning. 👇 Comment VALUE #Pharma #MarketAccess #AI #Pricing

You present evidence. They say: “we’ll review it.” And nothing happens. It’s not interest. It’s relevance. 👉 Swipe 📩 DM VALUE #Pharma #MarketAccess #HEOR #HTA

3 HTA agencies in LATAM. 0 clear AI rules. But dossiers with AI are already arriving. The advantage will go to teams that use AI with traceability, validation, and rigor. 👇 Read the full blog here: getquantus.ai/value-insights… #Pharma #MarketAccess #HEOR #AIinHealthcare #HTA

CONITEC and IETS still have no clear AI guidance for HTA evidence. That’s not a pause. It’s a window to set the benchmark. The teams that document rigor today will lead tomorrow. 👇Read the full blog here: getquantus.ai/value-insights… #Pharma #MarketAccess #HEOR #AIinHealthcare

Your product isn’t expensive. You’re telling the wrong story. Payers care about disease cost, not price. 👉 Swipe 📩 DM REAL COST #Pharma #MarketAccess #HEOR #HTA

$15K in training… 80% forgotten in weeks ❌ Not your team ❌ Your training model 🚀 No practice = no performance 📩 DM: MASTERY

Most pharma teams still spend 4–8 months building a GVD. AI is cutting that to weeks. Same rigor. Faster payer readiness. 👇 Read the full blog here---> getquantus.ai/value-insights… #Pharma #MarketAccess #HEOR #AIinHealthcare #HTA

A Global Value Dossier no longer needs 4–8 months. AI is already turning months into weeks—with the same methodological rigor. The real edge? Getting to HTA windows first. 👇 Read the full blog here--> getquantus.ai/value-insights… #Pharma #MarketAccess #HEOR #AI #HTA #GVD

You’re not losing because of the product. You’re losing because of the message. 💡 Payers think budget, not studies 🚀 Change the conversation 📩 DM: PRECISION

Brazil is now the toughest HTA market in LATAM. CONITEC + real-world data + AI = new rules for access. It’s not about better products. It’s about better evidence, faster. 👇 Link to read the blog getquantus.ai/value-insights… #Pharma #MarketAccess #HEOR #AIinHealthcare #HTA

🚀 Launching in 2026? Months-long studies + Generic messages = Lost market access Quantus + AI: Cut your strategic work in half ✅ Fast evidence ✅ Effective messages ✅ 24/7 training ✅ Measurable results 👉 DM "QUANTUS" for demo #MarketAccess #Pharma #AI

In market access: Dossier: 6 months Window: 3 months You’re late before you start. Not worse product. Slower process. AI = faster evidence, faster access. 👇 Read the full blog here getquantus.ai/value-insights… #Pharma #MarketAccess #HEOR #AIinHealthcare

Your biosimilar is 40% cheaper… yet you’re still losing contracts. The problem isn’t price. It’s not proving the savings. Payers need numbers they can defend. 💬 Comment SAVINGS. #Pharma #MarketAccess #Biosimilars #HealthEconomics

83% of pharma leaders think AI is overrated. They’re right… in R&D. But wrong in market access. Structured processes + AI = faster evidence, faster decisions. We break it down with real benchmarks. 👇Click here to read the blog. getquantus.ai/value-insights…

Quantus selected for eMerge Miami 🇺🇸 and Web Summit Rio 🇧🇷 Two global events validating what our clients already know: AI is transforming how pharma demonstrates value — and drives revenue. Want to see why? DM “QUANTUS” 🚀

Estamos felices de anunciar que QUANTUS fue seleccionada para participar en StartCo 2026, el escenario donde las ideas se conectan, las oportunidades crecen y el futuro se vive en tiempo real. Nos vemos el 16 y 17 de abril en Medellín @StarterCompany #StartCo2026

Your teams have evidence. But they’re not turning it into decisions. The problem isn’t the data. It’s the training. AI simulations = real practice with payers. 👉 DM QUANTUS. #Pharma #MarketAccess #HEOR #AIinHealthcare

If you want more approvals and reimbursements, evidence alone isn’t enough. You need to: • understand the payer • tailor the message • train with simulations • measure what works AI is already accelerating this. DM QUANTUS and we’ll show you how.

More molecules. Limited budgets. Tougher payers. Launching in 2026 requires a new playbook. AI + personalization + real training = faster traction. 👉 DM QUANTUS. #MarketAccess #Pharma #AIinHealth #HealthEconomics #MedTech